Defining Glenoid Track in Shoulder Instability: International Perspectives
- Eiji Itoi
Tohoku University School of Medicine, Sendai, Japan.
- Stephen Burkhart
The San Antonio Orthopaedic Group, San Antonio, TX.
- Giovanni Di Giacomo
Concordia Hospital, Rome, Italy.
Requirements for successful completion: In order to receive credit, participants must view all audio-visual presentations and complete both the pre-test, post-test and evaluation form. Participants must score 100% on the activity post-test in order to receive credit. There are no pre-requisites for this activity. Course attendance verification forms are provided upon successful completion of the post-test and evaluation form. No partial credit will be given.
Target Audience: Physicians, residents and trainees, fellows, nurses, surgical techs, physical therapists, and other members of the allied health community whose scope of practice encompasses Orthopaedics.
Course Description: In this live webinar, expert Sports Medicine, Shoulder/Elbow, Adult Reconstruction will present optimal operable techniques and treatment options to address Defining Glenoid Track in Shoulder Instability: International Perspectives. The webinar features time for interactive audience discussion and surgical case based scenarios.
Learning Objectives: Upon completion of this activity, participants should be better able to discuss:
- Discuss the basic concepts and clinical applications as they relate to the glenoid track
- Discuss arthroscopic measurement of the glenoid track
- Discuss techniques of arthroscopic remplissage for off-track lesions
- Discuss the role of the Hill Sacks lesion in shoulder instability
Credits: This lecture qualifies for 2 CME credit hours.
Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the International Institute for Continuing Medical Education and VuMedi. The International Institute for Continuing Medical Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide medical education to physicians.
Designation Statement: The International Institute for Continuing Medical Education, Inc designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty Disclosures: Faculty Disclosures/Conflict of Interest Policy\nIn accordance with ACCME requirements, The International Institute for Continuing Medical Education, Inc, has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced. The relationships were reviewed by The International Institute for Continuing Medical Education, Inc. and conflicts of interest were resolved prior to the activity.
Dr. Stephen Burkhart discloses the following relevant financial relationships with a commercial interest: consultant for, and royalties from Arthrex.
Dr. Eiji Itoi discloses he has no relevant financial relationships with any commercial interests in relation to this activity.
Dr. Giovanni Di Giacomo discloses the following relevant financial relationships with a commercial interest: consultant for, and royalties from Arthrex.
Faculty Disclosures of Unlabeled Use: The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
Dr. Stephen Burkhart does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
Dr. Eiji Itoi does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
Dr. Giovanni Di Giacomo does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
Commercial Support: No commercial support was received for this activity.
Copyright: Any and/or all materials are for the exclusive use of the faculty and participants of the live activity. Any copying, duplicating or reproducing of any and/or all materials by electronic, mechanical or other means for any purpose other than this enduring activity is strictly prohibited without prior written consent of the author of those materials.
Policy on Privacy and Confidentiality: For more information regarding VuMedi's Policy on Privacy and Confidentiality, please visit http://www.vumedi.com/pages/privacy/
To Contact our Accredited Provider: 6438 US Hwy 11
Springville, AL 35146
Phone: (205) 467-0290
Fax: (205) 467-0195
For questions regarding this activity, please contact VuMedi: firstname.lastname@example.org